Page last updated: 2024-08-23

bromocriptine and thioridazine

bromocriptine has been researched along with thioridazine in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19904 (30.77)18.7374
1990's4 (30.77)18.2507
2000's2 (15.38)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH1
Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Aronzon, R; Dorevitch, A; Stark, M1
Goldwasser, HD; Hooper, JF; Spears, NM1
Brust, J; Cohn, JB; DiSerio, F; Singer, J1
Kern, PA; Robbins, RJ; Thompson, TL1
Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME1
Freedman, MD1
Alkin, T; Demopulos, CM; Ozerdem, A; Sagduyu, K; Yildiz, A1

Reviews

2 review(s) available for bromocriptine and thioridazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Maryland medical journal (Baltimore, Md. : 1985), 1997, Volume: 46, Issue:7

    Topics: Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Myocardial Infarction; Neuroleptic Malignant Syndrome; Thioridazine

1997

Other Studies

11 other study(ies) available for bromocriptine and thioridazine

ArticleYear
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
    Nature, 1991, Apr-18, Volume: 350, Issue:6319

    Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection

1991
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:9

    Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri

1986
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia.
    Acta obstetricia et gynecologica Scandinavica, 1991, Volume: 70, Issue:4-5

    Topics: Acute Disease; Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Psychoses, Substance-Induced; Schizophrenia, Paranoid; Thioridazine

1991
Concomitant treatment of neuroleptic malignant syndrome and psychosis.
    The British journal of psychiatry : the journal of mental science, 1989, Volume: 154

    Topics: Adult; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Thioridazine

1989
Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.
    Neuropsychobiology, 1985, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Sex Factors; Thioridazine

1985
Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
    The American journal of medicine, 1984, Volume: 76, Issue:5

    Topics: Adenoma; Adult; Bromocriptine; Drug Interactions; Humans; Male; Pituitary Neoplasms; Prolactin; Schizophrenia, Paranoid; Thioridazine; Tomography, X-Ray Computed; Visual Fields

1984
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
    Journal of child and adolescent psychopharmacology, 1997,Spring, Volume: 7, Issue:1

    Topics: Adolescent; Amenorrhea; Antipsychotic Agents; Bromocriptine; Clozapine; Female; Fluphenazine; Galactorrhea; Haloperidol; Humans; Hyperprolactinemia; Prolactin; Psychotic Disorders; Thioridazine

1997
Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
    The Australian and New Zealand journal of psychiatry, 2003, Volume: 37, Issue:4

    Topics: Acute-Phase Proteins; Adult; Antipsychotic Agents; Bromocriptine; Clopenthixol; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Thioridazine

2003